Your browser doesn't support javascript.
loading
Clinical response to immune checkpoint inhibition in patients with advanced skin cancers receiving concurrent ruxolitinib therapy for haematological malignancy.
Haddad, N; Delyon, J; Trabelsi Messai, S; Herms, F; Leccia, M T; Lebbe, C; Whitney, J; Bhatia, S; Basset-Seguin, N.
Affiliation
  • Haddad N; Department of Dermatology, AP-HP Saint-Louis Hospital, Paris, France.
  • Delyon J; Department of Dermatology, AP-HP Saint-Louis Hospital, Paris, France.
  • Trabelsi Messai S; Department of Dermatology, Université de Paris VII Diderot, Sorbonne Université Cité, Paris, France.
  • Herms F; INSERM HIPI, Université de Paris VII Diderot, Sorbonne Université Cité, Paris, France.
  • Leccia MT; Dermatology Department, CHU de Grenoble, Grenoble, France.
  • Lebbe C; Department of Dermatology, AP-HP Saint-Louis Hospital, Paris, France.
  • Whitney J; Dermatology Department, CHU de Grenoble, Grenoble, France.
  • Bhatia S; Department of Dermatology, AP-HP Saint-Louis Hospital, Paris, France.
  • Basset-Seguin N; Department of Dermatology, Université de Paris VII Diderot, Sorbonne Université Cité, Paris, France.
Br J Dermatol ; 184(3): 564-566, 2021 03.
Article in En | MEDLINE | ID: mdl-33058221
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Hematologic Neoplasms Limits: Humans Language: En Journal: Br J Dermatol Year: 2021 Document type: Article Affiliation country: France Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Hematologic Neoplasms Limits: Humans Language: En Journal: Br J Dermatol Year: 2021 Document type: Article Affiliation country: France Country of publication: United kingdom